| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 247 | 25 | 50 | 118 | | Cost of Revenue | 141 | 3 | 0 | 55 | | | Gross Profit | 107 | 22 | 50 | 64 | | | Operating Expenses | | Research Development | 397 | 430 | 535 | 544 | | Selling General and Administrative | 639 | 804 | 993 | 1,592 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5 | 6 | 7 | 31 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (935) | (1,219) | (1,486) | (2,103) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 2 | 171 | (150) | | Earnings Before Interest And Taxes | (924) | (1,226) | (1,315) | (2,252) | | Interest Expense | 24 | 24 | 23 | 14 | | Income Before Tax | (948) | (1,250) | (1,338) | (2,267) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (948) | (1,250) | (1,338) | (2,267) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (948) | (1,250) | (1,338) | (2,267) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($948) | ($1,250) | ($1,338) | ($2,267) |
|
0.01% Nasdaq 0.00%
Income Statement
